Did We Know About Liver Problems Related to Ketek Before It's Release?
Weitz and Luxenberg is no longer accepting Ketek cases.
Based on the pre-marketing clinical data it appeared that the risk of liver injury with telithromycin was similar to that of other marketed antibiotics.
FDA looked extensively at the potential for hepatic toxicity in patients treated with Ketek.Data was examined from clinical studies, as well as information in nearly 4 million postmarketing prescriptions outside the United States.
Ketek was the subject of two advisory committee meetings with input from a national expert on drug-induced liver disease.
The committee concluded that the risk for hepatotoxicity from Ketek was similar to Augmentin and erythromycin which are other approved antibiotics.
Act Now! It is essential that you inquire about your Ketek lawsuit as soon as possible. Your individual state's law may limit your time to bring a legal claim to protect your rights. Your legal review is free and there is no commitment. Your case will be evaluated immediately, so get started on your claim today!
see also:
Ketek Precautions
Ketek Precautions - You May Be At Risk!The Danger behind Ketek - A new FDA warning
Ketek Symptoms
Ketek Symptoms - Know if You are ExposedThe Danger behind Ketek - A new FDA warning
News & Warnings
Breaking Ketek (Telithromycin) News from Dangerous Drug AttorneysBreaking Ketek News & FREE Lawsuit Evaluation from Ketek Attorneys

